Candriam Equities L Oncology Impact PI
LU1864483836
Candriam Equities L Oncology Impact PI/ LU1864483836 /
NAV 05.06.2024
Diff.+28,4700
Ertragstyp
Ausrichtung
Fondsgesellschaft
2.558,2000 USD
+1,13%
thesaurierend
Aktien
weltweit
Candriam ▶
Kennzahlen und Performance in:
Alle Kurse in USD
Tranchen
Titel
Ertragstyp
Rückn. Preis
1 Jahr
3 Jahre
Candriam Equities L Oncology Imp...
thesaurierend
2.393,9099
+7,72%
+4,62%
Candriam Equities L Oncology Imp...
thesaurierend
2.558,2000
+7,86%
+5,01%
Candriam Equities L Oncology Imp...
thesaurierend
207,0400
+4,18%
-6,19%
Candriam Equities L Oncology Imp...
thesaurierend
2.229,6499
+4,43%
+15,08%
Candriam Equities L Oncology Imp...
ausschüttend
1.606,3300
+7,38%
+3,61%
Candriam Equities L Oncology Imp...
thesaurierend
244,6500
+4,85%
+12,98%
Candriam Equities L Oncology Imp...
ausschüttend
235,4400
+6,37%
+0,75%
Candriam Equities L Oncology Imp...
ausschüttend
190,7200
+7,27%
+3,31%
Candriam Equities L Oncology Imp...
ausschüttend
20.641,0000
+2,52%
+0,59%
Candriam Equities L Oncology Imp...
thesaurierend
157,7300
+4,31%
+14,69%
Candriam Equities L Oncology Imp...
thesaurierend
2.106,0200
+5,17%
-3,50%
Candriam Equities L Oncology Imp...
thesaurierend
259,3200
+5,74%
+15,86%
Candriam Equities L Oncology Imp...
thesaurierend
206,4900
+3,76%
-7,29%
Candriam Equities L Oncology Imp...
thesaurierend
285,9900
+7,27%
+3,30%
Candriam Equities L Oncology Imp...
thesaurierend
193,4200
+5,05%
-
Candriam Equities L Oncology Imp...
thesaurierend
1.839,3500
+4,77%
-
Candriam Equities L Oncology Imp...
thesaurierend
2.843,2800
+6,18%
+3,59%
Candriam Equities L Oncology Imp...
thesaurierend
157,2500
-
-
Candriam Equities L Oncology Imp...
thesaurierend
270,5100
+5,19%
+0,71%
Performance
lfd. Jahr
+8,57%
6 Monate
+14,18%
1 Jahr
+7,86%
3 Jahre
+5,01%
5 Jahre
+69,26%
10 Jahre
-
seit Beginn
+69,79%
Jahr
2023
+1,56%
2022
-9,27%
2021
+3,90%
2020
+33,03%